EU-PIC Partners

These are our Partners. Participate or join us now!

PGx diagnostic groups



PGx diagnostic groups

NETHERLANDS

Erasmus MC Rotterdam (EMC)

International Expertcenter PGx

Prof Dr Ron HN van Schaik (Clinical Chem)

Prof Dr Teun van Gelder (Internal med)

Prof Dr Ron Mathijssen (Oncology)

Dr Birgit Koch (Hospital Pharmacy)

Dr Sandra Heil (Clin CHem)

Drs Maja Matic (Clinical Chem)

www.erasmusmc.nl/farmacogenetica 

See for other Dutch labs: www.pgx-net.nl  


AUSTRIA

Paracelsus Medical Private University, Salzburg (PMU)

Prof Dr Markus Paulmichl

Dr Charity Nofziger


BELGIUM

UCL Bruxelle (UCL)

Prof Dr Vincent Haufroid


CROATIA 

University Hospital Center Zagreb

Assoc. Prof. Nada Božina


DENMARK 

Vejle Hospital

Prof Dr Ivan Brandslund

Syddansk Universitet

Prof Dr Kim Brosen


FINLAND

University of Helsinki (UH)

Prof Dr Mikko Niemi


FRANCE

CHU Limoges (LIM)

Prof Dr Pierre Marquet


GERMANY

Christian-Albrechts Universität Kiel (CAU)

Prof Dr Ingolf Cascorbi


GREECE

Democrtitus University of Thrace Alexandropoulis (DUTH)

Prof Dr Vangelis Manoloupoulis

Dr Anna Tavridou

University of Patras (UPAT)

Prof Dr George Patrinos


HUNGARY

Semmelweis University Budapest (SEM)

Prof Dr Maria Judit Molnar

Prof Dr Marta Szegedi


ITALY

University of Pisa (UNIPI)

Prof Dr Romano Danesi

Dr Marzia del Re

 

Universita degli Stui di Roma la Sapienza (RSAP)

Prof Dr Maurizio Simmaco

 

Ospedale San Rafaelle Milano

Prof Dr Maurizio Ferrari

Dr Monica Zannusi


POLAND

Jaggiellonian University of Krakow (UJK)

Prof Dr Iwona Wybranska


PORTUGAL

Instituto Português de Oncologia, Porto (IPOP)

Prof Dr Rui Medeiros 


SLOVENIA

University of Lubljana (UNILJ)

Prof Dr Janja Marc 

Prof Dr Vita Dolzan


SWEDEN

Karolinska Institutet Stockholm (KI)

Dr Marja-Liisa Dahl


TURKEY

Marmara University

Prof Dr Belgin Süsleyici Duman


 

Contact | Login | Registration

Pharmacogenetics

Our purpose: implementing and supporting Pharmacogenetics for the most important and actionable pharmacogenetic markers into clinical care and monitor uptake and experiences.

Personalised medicine

Personalised medicine has the potential to respond to, amongst others, the increasing burden of chronic disease and the complexity of co-morbidities and in doing so contribute to the sustainability of health and care systems. 

Where to find us

Address
's Gravendijkwal 230
3015 CE Rotterdam
Contactperson
Prof. Dr. R.H.N. van Schaik | Dept. Clinical Chemistry, Erasmus MC Rotterdam